Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Ophthalmological Medicine
Volume 2018, Article ID 4375354, 4 pages
https://doi.org/10.1155/2018/4375354
Case Report

A Rare Presentation of Actinic Keratosis Affecting the Tarsal Conjunctiva and Review of the Literature

Ophthalmology Department, Great Western Hospital, Swindon, UK

Correspondence should be addressed to Selina Khan; ku.ca.lotsirb.ym@5017ks

Received 31 October 2017; Accepted 15 January 2018; Published 12 February 2018

Academic Editor: Alexander A. Bialasiewicz

Copyright © 2018 Selina Khan and Melanie Chak. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Shields and C. Shields, Eyelid, Conjunctival, and Orbital Tumours: An Atlas and Textbook, Williams and Wilkins, 2nd edition, 2008, Lippincott.
  2. P. G. Lang Jr., “Management of Actinic Keratoses,” Comprehensive Therapy, vol. 29, no. 2-3, pp. 108–114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Vogelstein, S. Sur, and C. Prives, “p53: The Most Frequently Altered Gene in Human Cancers,” Nature Education, vol. 3, no. 9, p. 6, 2010. View at Google Scholar
  4. L. Naldi, L. Chatenoud, R. Piccitto, P. Colombo, E. B. Placchesi, and C. La Vecchia, “Prevalence of actinic keratoses and associated factors in a representative sample of the italian adult population,” JAMA Dermatology, vol. 142, no. 6, pp. S785–S789, 2006. View at Publisher · View at Google Scholar
  5. J. Anwar, D. A. Wrone, A. Kimyai-Asadi, and M. Alam, “The development of actinic keratosis into invasive squamous cell carcinoma: Evidence and evolving classification schemes,” Clinics in Dermatology, vol. 22, no. 3, pp. 189–196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. S. M. Couch and P. L. Custer, “Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy,” Ophthalmic Plastic & Reconstructive Surgery, vol. 28, no. 3, pp. 181–183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. A. H. Ross, C. T. C. Kennedy, C. Collins, and R. A. Harrad, “The use of imiquimod in the treatment of periocular tumours,” Orbit, vol. 29, no. 2, pp. 83–87, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Rowlands, J. N. Giacometti, J. Servat, M. A. Materin, and F. Levin, “Topical Imiquimod in the Treatment of Conjunctival Actinic Keratosis,” Ophthalmic Plastic & Reconstructive Surgery, vol. 33, no. 1, pp. e21–e23, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Mortemousque, F. Leger, C. Brindeau et al., “Actinic keratosis of the conjunctiva. Apropos of a clinical case,” Journal Français D'Ophtalmologie, vol. 21, no. 6, pp. 458–461, 1998. View at Google Scholar
  10. F. D'Hermies, J. Cotinat, C. Elmaleh et al., “Bilateral actinic keratosis of the corneal limbus. Apropos of a case,” Journal Français D'Ophtalmologie, vol. 15, 65, no. 1, p. 67, 1992. View at Google Scholar
  11. J. A. Mauriello Jr, J. Napolatino, and I. McLean, “Actinic keratosis and dysplasia of conjunctiva: A clinicopathological study of 45 cases,” Canadian Journal of Ophthalmology, vol. 30, p. 312, 1995. View at Google Scholar
  12. D. Siegal, S. Tyring, and W. Nahm, “Three-day field treatment with Ingenol Disoxate 0.018% for actinic keratosis: A phase II trial,” The Journal of Clinical and Aesthetic Dermatology, vol. 10, no. 12, pp. 19–26, 2017. View at Google Scholar
  13. C. Costa, M. Scalvenzi, F. Ayala, G. Fabbrocini, and G. Monfrecola, “How to treat actinic keratosis? An update,” Journal of Dermatological Case Reports, vol. 9, no. 2, pp. 29–35, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Stockfleth, C. Harwood, C. Serra Guillén, T. Larsson, M. L. Østerdal, and T. Skov, “Phase IV head-to-head randomised controlled trial comparing ingenol mebutate 0.015% with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp,” British Journal of Dermatology, 2017. View at Publisher · View at Google Scholar
  15. R. Batra, S. Sundararajan, and S. Sandramouli, “Topical diclofenac gel for the management of periocular actinic keratosis,” Ophthalmic Plastic & Reconstructive Surgery, vol. 28, no. 1, pp. 1–3, 2012. View at Publisher · View at Google Scholar · View at Scopus